<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font25">and </span>
   <span class="font14">for </span>
   <span class="font13">HIV- </span>
   <span class="font13">sequences </span>
   <span class="font13">were </span>
   <span class="font13">with </span>
   <span class="font13">integrase </span>
   <span class="font13">The </span>
   <span class="font13">was </span>
   <span class="font12">genetic </span>
   <span class="font12">from </span>
   <span class="font12">that </span>
   <span class="font12">mutations </span>
   <span class="font12">resistance </span>
   <span class="font12">subtype </span>
   <span class="font12">{background </span>
   <span class="font11">which </span>
   <span class="font11">HIV </span>
   <span class="font11">polymorphic </span>
   <span class="font11">this </span>
   <span class="font11">patients </span>
   <span class="font11">barrier </span>
   <span class="font11">positions </span>
   <span class="font11">sub-subtype </span>
   <span class="font11">had </span>
   <span class="font11">margin </span>
   <span class="font11">INSTI </span>
   <span class="font11">drug </span>
   <span class="font11">{border-style </span>
   <span class="font11">mutation </span>
   <span class="font11">Russia </span>
   <span class="font11">are </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Integrase </span>
   <span class="font11">have </span>
   <span class="font11">polymorphisms </span>
   <span class="font11">among </span>
   <span class="font10">[]. </span>
   <span class="font10">can </span>
   <span class="font10">different </span>
   <span class="font10">treatment </span>
   <span class="font10">ATA </span>
   <span class="font10">between </span>
   <span class="font10">analysis </span>
   <span class="font10">than </span>
   <span class="font10">viral </span>
   <span class="font10">data </span>
   <span class="font10">samples </span>
   <span class="font10">INSTIs </span>
   <span class="font10">clade </span>
   <span class="font10">clinical </span>
   <span class="font10">codon </span>
   <span class="font10">one </span>
   <span class="font10">prevalence </span>
   <span class="font10">treatment-naÃ¯ve </span>
   <span class="font10">used </span>
   <span class="font10">.%), </span>
   <span class="font10">highly </span>
   <span class="font10">position </span>
   <span class="font10">showed </span>
   <span class="font10">substitutions </span>
   <span class="font10">virological </span>
   <span class="font10">Resistance </span>
   <span class="font10">Russian </span>
   <span class="font10">amino </span>
   <span class="font10">determined </span>
   <span class="font10">features </span>
   <span class="font10">most </span>
   <span class="font10">number </span>
   <span class="font10">occurring </span>
   <span class="font10">other </span>
   <span class="font10">phylogenetic </span>
   <span class="font10">px; </span>
   <span class="font10">significantly </span>
   <span class="font10">subtypes </span>
   <span class="font10">these </span>
   <span class="font10">using </span>
   <span class="font10">{font-family </span>
   <span class="font10">(GA) </span>
   <span class="font10">ATG </span>
   <span class="font10">DRMs </span>
   <span class="font10">For </span>
   <span class="font10">INSTI-naÃ¯ve </span>
   <span class="font10">all </span>
   <span class="font10">been </span>
   <span class="font10">catalytic </span>
   <span class="font10">defined </span>
   <span class="font10">detected </span>
   <span class="font10">effect </span>
   <span class="font10">font-size </span>
   <span class="font10">founder </span>
   <span class="font10">important </span>
   <span class="font10">indicated </span>
   <span class="font10">more </span>
   <span class="font10">mutations, </span>
   <span class="font10">not </span>
   <span class="font10">obtained </span>
   <span class="font10">online: </span>
   <span class="font10">role </span>
   <span class="font10">strand </span>
   <span class="font10">study </span>
   <span class="font10">sub-subtypes </span>
   <span class="font10">viruses </span>
   <span class="font10">Additionally, </span>
   <span class="font10">Analysis </span>
   <span class="font10">TTC/T </span>
   <span class="font10">Table </span>
   <span class="font10">[,,], </span>
   <span class="font10">core </span>
   <span class="font10">described </span>
   <span class="font10">development </span>
   <span class="font10">domain </span>
   <span class="font10">domain, </span>
   <span class="font10">double; </span>
   <span class="font10">epidemic </span>
   <span class="font10">frequency </span>
   <span class="font10">has </span>
   <span class="font10">impact </span>
   <span class="font10">inhibitor </span>
   <span class="font10">major </span>
   <span class="font10">only </span>
   <span class="font10">patients, </span>
   <span class="font10">region </span>
   <span class="font10">studies </span>
   <span class="font10">susceptibility </span>
   <span class="font10">therapy </span>
   <span class="font10">transfer </span>
   <span class="font10">use </span>
   <span class="font10">variability </span>
   <span class="font10">variants </span>
   <span class="font10">Antimicrob. </span>
   <span class="font10">Database </span>
   <span class="font10">Drug </span>
   <span class="font10">EVG </span>
   <span class="font10">FSU </span>
   <span class="font10">Genetic </span>
   <span class="font10">Infect. </span>
   <span class="font10">Therefore, </span>
   <span class="font10">This </span>
   <span class="font10">about </span>
   <span class="font10">acid </span>
   <span class="font10">affect </span>
   <span class="font10">also </span>
   <span class="font10">analyzed </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">approved </span>
   <span class="font10">associated </span>
   <span class="font10">barriers </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">differences </span>
   <span class="font10">estimated </span>
   <span class="font10">identified </span>
   <span class="font10">including </span>
   <span class="font10">mutation, </span>
   <span class="font10">patient </span>
   <span class="font10">patients. </span>
   <span class="font10">replication </span>
   <span class="font10">resistance, </span>
   <span class="font10">resistance. </span>
   <span class="font10">respectively. </span>
   <span class="font10">solid; </span>
   <span class="font10">spread </span>
   <span class="font10">substitution </span>
   <span class="font10">tree </span>
   <span class="font10">tv, </span>
   <span class="font10">understanding </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">â€" </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">&amp;lt;% </span>
   <span class="font10">(.%). </span>
   <span class="font10">.%). </span>
   <span class="font10">Agents </span>
   <span class="font10">Antiretroviral </span>
   <span class="font10">Barrier </span>
   <span class="font10">C-terminal </span>
   <span class="font10">Codon </span>
   <span class="font10">D.A.M.C.v.d.V., </span>
   <span class="font10">FLAIR </span>
   <span class="font10">Figure </span>
   <span class="font10">However, </span>
   <span class="font10">LI, </span>
   <span class="font10">Los </span>
   <span class="font10">March </span>
   <span class="font10">Mutation </span>
   <span class="font10">Mutations </span>
   <span class="font10">N-terminal </span>
   <span class="font10">Naturally </span>
   <span class="font10">Phylogenetic </span>
   <span class="font10">Polymorphisms </span>
   <span class="font10">Resistant </span>
   <span class="font10">Type </span>
   <span class="font10">[,,,]. </span>
   <span class="font10">accessory </span>
   <span class="font10">according </span>
   <span class="font10">across </span>
   <span class="font10">active </span>
   <span class="font10">analysis, </span>
   <span class="font10">article </span>
   <span class="font10">bold </span>
   <span class="font10">capacity </span>
   <span class="font10">clades </span>
   <span class="font10">coding </span>
   <span class="font10">codons </span>
   <span class="font10">compared </span>
   <span class="font10">courier; </span>
   <span class="font10">em; </span>
   <span class="font10">first </span>
   <span class="font10">high </span>
   <span class="font10">included </span>
   <span class="font10">indicates </span>
   <span class="font10">inhibitors </span>
   <span class="font10">lower </span>
   <span class="font10">majority </span>
   <span class="font10">may </span>
   <span class="font10">natural </span>
   <span class="font10">naturally </span>
   <span class="font10">non-B </span>
   <span class="font10">occurrence </span>
   <span class="font10">part </span>
   <span class="font10">performed </span>
   <span class="font10">pt;} </span>
   <span class="font10">regimen </span>
   <span class="font10">required </span>
   <span class="font10">resistant </span>
   <span class="font10">score </span>
   <span class="font10">scored </span>
   <span class="font10">selection </span>
   <span class="font10">similar </span>
   <span class="font10">studied </span>
   <span class="font10">there </span>
   <span class="font10">transitions </span>
   <span class="font10">transversions </span>
  </p>
 </body>
</html>
